Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C.L. Ong is active.

Publication


Featured researches published by C.L. Ong.


Radiotherapy and Oncology | 2010

Stereotactic radiotherapy for peripheral lung tumors: A comparison of volumetric modulated arc therapy with 3 other delivery techniques

C.L. Ong; Wilko F.A.R. Verbakel; Johan P. Cuijpers; Ben J. Slotman; Frank J. Lagerwaard; Suresh Senan

PURPOSE Volumetric modulated arc therapy (RapidArc) allows for fast delivery of stereotactic body radiotherapy (SBRT) delivery in stage I lung tumors. We compared dose distributions and delivery times between RapidArc and common delivery techniques in small tumors. METHODS In 18 patients who completed RapidArc SBRT for tumors measuring <70 cm(3), new treatment plans were generated using non-coplanar 3D conformal fields (conf-SBRT) and dynamic conformal arc radiotherapy (DCA). For 9 patients with tumors adjacent to the chest wall, co-planar intensity-modulated radiotherapy (IMRT) plans were also generated. PTV dose coverage, organs at risk (OAR) doses and treatment delivery times were assessed. RESULTS RapidArc plans achieved a superior conformity index (CI) and lower V(45 Gy) to chest wall (p<0.05) compared to all other techniques. RapidArc led to a small increase in V(5 Gy) to contralateral lung compared to conf-SBRT (4.4±4% versus 1.2±1.8%, p=0.011). For other OAR, RapidArc and conf-SBRT plans were comparable, and both were superior to DCA plans. Delivery of a 7.5 Gy-fraction required 3.9 min (RapidArc), 11.6 min (conf-SBRT), and 12 min (IMRT). CONCLUSIONS In stage I lung tumors measuring <70 cm(3), RapidArc plans achieved both the highest dose conformity and shortest delivery times.


Radiotherapy and Oncology | 2010

Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity

C.L. Ong; David Palma; Wilko F.A.R. Verbakel; Ben J. Slotman; Suresh Senan

PURPOSE To study the dosimetric predictors of early clinical toxicity following SBRT in patients with lung tumors and planning target volumes (PTV) exceeding 80 cm(3). METHODS Eighteen consecutive patients who were treated using volumetric modulated arc therapy (RapidArc™) were assessed. All were either unfit or refused to undergo surgery or chemoradiotherapy. PTV planning objectives were as used in the ROSEL study protocol. Clinical toxicity was scored using Common Toxicity Criteria AE4.0. Lung volumes receiving 5, 10, 15, and 20 Gy (V(5), V(10), V(15) and V(20)) and mean lung dose were assessed and correlated to symptomatic radiation pneumonitis (RP). RESULTS Median age, age-adjusted Charlson-comorbidity score and PTV size were 74, 7.5 and 137 cm(3), respectively. At a median follow-up of 12.8 months, 8 deaths were recorded: 5 arising from comorbidity, 2 were potentially treatment-related and 1 had local recurrence. RP was reported in 5 patients (grade 2 in 3 and grade 3 in 2). All RP occurred in plans without a high priority optimization objective on contralateral lung. Acute RP was best predicted by contralateral lung V(5) (p<0.0001). CONCLUSION After SBRT using RapidArc in lung tumors >80 cm(3), the contralateral lung V(5) best predicts RP. Limiting contralateral lung V(5) to <26% may reduce acute toxicity.


International Journal of Radiation Oncology Biology Physics | 2012

Fast Arc Delivery for Stereotactic Body Radiotherapy of Vertebral and Lung Tumors

C.L. Ong; Wilko F.A.R. Verbakel; Max Dahele; Johan P. Cuijpers; Ben J. Slotman; Suresh Senan

PURPOSE Flattening filter-free (FFF) beams with higher dose rates and faster delivery are now clinically available. The purpose of this planning study was to compare optimized non-FFF and FFF RapidArc plans for stereotactic body radiotherapy (SBRT) and to validate the accuracy of fast arc delivery. METHODS AND MATERIAL Ten patients with peripheral lung tumors and 10 with vertebral metastases were planned using RapidArc with a flattened 6-MV photon beam and a 10-MV FFF beam for fraction doses of 7.5-18 Gy. Dosimetry of the target and organs at risk (OAR), number of monitor units (MU), and beam delivery times were assessed. GafChromic EBT2 film measurements of FFF plans were performed to compare calculated and delivered dose distributions. RESULTS No major dosimetric differences were seen between the two delivery techniques. For lung SBRT plans, conformity indices and OAR doses were similar, although the average MU required were higher with FFF plans. For vertebral SBRT, FFF plans provided comparable PTV coverage, with no significant differences in OAR doses. Average beam delivery times were reduced by a factor of up to 2.5, with all FFF fractions deliverable within 4 min. Measured FFF plans showed high agreement with calculated plans, with more than 99% of the area within the region of interest fulfilling the acceptance criterion. CONCLUSION The higher dose rate of FFF RapidArc reduces delivery times significantly, without compromising plan quality or accuracy of dose delivery.


Medical Physics | 2011

Impact of the calculation resolution of AAA for small fields and RapidArc treatment plans

C.L. Ong; Johan P. Cuijpers; Suresh Senan; Ben J. Slotman; Wilko F.A.R. Verbakel

PURPOSE To investigate the impact of the calculation resolution of the anisotropic analytical algorithms (AAA) for a variety of small fields in homogeneous and heterogeneous media and for RapidArc plans. METHODS Dose distributions calculated using AAA version 8.6.15 (AAA8) and 10.0.25 (AAA10) were compared to measurements performed with GafChromic EBT film, using phantoms made of polystyrene or a combination of polystyrene and cork. The accuracy of the algorithms calculated using grid resolutions of 2.5 and 1.0 mm was investigated for different field sizes, and for a limited selection of RapidArc plans (head and neck, small meningioma, and lung). Additional plans were optimized to create excessive multileaf collimator modulation and measured on a homogenous phantom. Gamma evaluation criterion of 3% dose difference and 2- or 1-mm distance to agreement (DTA) were applied to evaluate the accuracy of the algorithms. RESULTS For fields ≤3 × 3 cm2 , both versions of AAA predicted lower peak doses and broader penumbra widths than the measurements. However, AAA10 and a finer calculation grid improved the agreement. For RapidArc plans with many small multileaf collimator (MLC) segments and relatively high number of monitor units (MU), AAA8 failed to identify small dose peaks within the target. Both versions performed better in polystyrene than in cork. In homogeneous cork layers, AAA8 underestimated the average target dose for a clinical lung plan. This was improved with AAA10 calculated using a 1 mm grid. CONCLUSIONS AAA10 improves the accuracy of dose calculations, and calculation grid of 1.0 mm is superior to using 2.5 mm, although calculation times increased by factor of 5. A suitable upper MU constraint should be assigned during optimization to avoid plans with high modulation. For plans with a relative high number of monitor units, calculations using 1 mm grid resolution are recommended. For planning target volume (PTV) which contains relatively large area of low density tissue, users should be aware of possible dose underestimation in the low density region and recalculation with AAA10 grid 1.0 mm is recommended.


International Journal of Radiation Oncology Biology Physics | 2013

Dosimetric Impact of Intrafraction Motion During RapidArc Stereotactic Vertebral Radiation Therapy Using Flattened and Flattening Filter-Free Beams

C.L. Ong; Max Dahele; Johan P. Cuijpers; Suresh Senan; Ben J. Slotman; Wilko F.A.R. Verbakel

PURPOSE To study the dosimetric impact of relatively short-duration intrafraction shifts during a single fraction of RapidArc delivery for vertebral stereotactic body radiation therapy (SBRT) using flattened (FF) and flattening filter-free (FFF) beams. METHODS AND MATERIALS The RapidArc plans, each with 2 to 3 arcs, were generated for 9 patients using 6-MV FF and 10-MV FFF beams with maximum dose rates of 1000 and 2400 MU/min, respectively. A total of 1272 plans were created to estimate the dosimetric consequences in target and spinal cord volumes caused by intrafraction shifts during one of the arcs. Shifts of 1, 2, and 3 mm for periods of 5, 10, and 30 seconds, and 5 mm for 5 and 10 seconds, were modelled during a part of the arc associated with high doses and steep dose gradients. RESULTS For FFF plans, shifts of 2 mm over 10 seconds and 30 seconds could increase spinal cord Dmax by up to 6.5% and 13%, respectively. Dosimetric deviations in FFF plans were approximately 2-fold greater than in FF plans. Reduction in target coverage was <1% for 83% and 96% of the FFF and FF plans, respectively. CONCLUSION Even short-duration intrafraction shifts can cause significant dosimetric deviations during vertebral SBRT delivery, especially when using very high dose rate FFF beams and when the shift occurs in that part of the arc delivering high doses and steep gradients. The impact is greatest on the spinal cord and its planning-at-risk volume. Accurate and stable patient positioning is therefore required for vertebral SBRT.


International Journal of Radiation Oncology Biology Physics | 2013

Dosimetric Impact of the Interplay Effect During Stereotactic Lung Radiation Therapy Delivery Using Flattening Filter-Free Beams and Volumetric Modulated Arc Therapy

C.L. Ong; Max Dahele; Ben J. Slotman; Wilko F.A.R. Verbakel


International Journal of Radiation Oncology Biology Physics | 2012

Flattening Filter-free Beams for SBRT: Advantages and Risks

Wilko F.A.R. Verbakel; C.L. Ong; S. Senan; Johan P. Cuijpers; B.J. Slotman; Max Dahele


International Journal of Radiation Oncology Biology Physics | 2009

Dosimetric Validation of RapidArc for Stereotactic Radiotherapy for Peripheral Lung Tumors

Johan P. Cuijpers; C.L. Ong; F.J. Lagerwaard; S. Senan; B.J. Slotman; Wilko F.A.R. Verbakel


Radiotherapy and Oncology | 2015

PD-0460: Performance of digital tomosnythesis for tumor motion monitoring: a phantom study

C.L. Ong; Max Dahele; B.J. Slotman; Wilko F.A.R. Verbakel


Radiotherapy and Oncology | 2013

PD-0040: Dosimetric impact of interplay during lung SBRT with FFF RapidArc

C.L. Ong; Max Dahele; B.J. Slotman; Wilko F.A.R. Verbakel

Collaboration


Dive into the C.L. Ong's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

B.J. Slotman

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Max Dahele

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

S. Senan

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Johan P. Cuijpers

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ben J. Slotman

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Suresh Senan

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Palma

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

F.J. Lagerwaard

Erasmus University Rotterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge